Andrea Marzi
From Wikipedia, the free encyclopedia
Andrea Marzi | |
|---|---|
 | |
| Alma mater | University of Erlangen–Nuremberg (PhD) |
| Awards | Loeffler-Frosch medal (2019) |
| Scientific career | |
| Fields | Immunobiology, molecular virology |
| Institutions | National Microbiology Laboratory Rocky Mountain Laboratories |
| Thesis | The role of cellular attachment factors for filovirus infection (2007) |
| Doctoral advisor | Uwe Sonnewald |
Andrea Marzi is a German-American virologist. She is chief of the immunobiology and molecular virology unit at the Rocky Mountain Laboratories. Marzi investigates the pathogenesis of filoviruses and vaccine development. She received the Loeffler-Frosch medal in recognition of her research.
In 2007, Marzi received a Ph.D. in virology from the University of Erlangen–Nuremberg where she studied the glycoprotein-mediated entry of Ebola virus (EBOV) and HIV.[1] Her doctoral advisor was Uwe Sonnewald. Her dissertation was titled The role of cellular attachment factors for filovirus infection.[2] Later that year, Marzi moved to Winnipeg to join Heinz Feldmann’s group at the National Microbiology Laboratory to work in the Biological Safety Level 4 (BSL4) on filoviruses and EBOV vaccines.[1]
